Teva Pharmaceutical Industries (NYSE:TEVA)

Big Pharma Sees a Rising Tide in Short Interest

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Agilent, Allergan, Beyond Meat, Canopy Growth, Dollar Tree, Facebook, Luckin Coffee, Lyft, Mylan, Symantec, Tilray, Wells Fargo and More

Stocks were indicated to open higher yet again on Tuesday, as June has turned into a complete role reversal from May's "sell in May" theme that was winning. Investors need ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Alcon, Analog Devices, Big Lots, CACI, CenterPoint, Cree, Lyft, Teva, WellCare and More

Stocks were indicated to open marginally lower on Monday on continued international market reactions to trade war and tariff woes. That excuse may be getting rather old, but each day ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Apple, Citigroup, Comcast, Cypress Semi, Huya, Six Flags, Tesla, Teva, US Steel, Verizon, Zynga and More

Stocks were indicated to open marginally higher after Wednesday's sell-off marked a two-day slide on continued trade war fears. Investors probably are wondering if they should have listened to the ...
Read Full Story »

Big Pharma Short Sellers Hike Their Bets

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Big Pharma Scares Off Short Sellers

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Big Pharma Scares Off Short Sellers

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Unbelievable Swings in Big Pharma Short Interest

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Bunge, Carbonite, FedEx, Kinder Morgan, Micron, Monster Beverage, Teva, Western Digital and More

Stocks were indicated to open marginally lower on Thursday morning, and the market has felt a bit directionless of late while it awaits a trade deal with China. Investors need ...
Read Full Story »

Major Pharma Sees a Few Wild Swings in Short Interest

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Allergan, Costco, Cree, Dollar Tree, Eli Lilly, FedEx, Mylan, NextEra, Peabody, Teva, Yum Brands and More

Stocks were indicated to open marginally higher on Wednesday ahead of the FOMC decision on interest rates. With the market having recouped so much ground in 2019, investors need to ...
Read Full Story »

Big Pharma Short Interest Backs Off, With One Huge Exception

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Flop City: 7 Big Stocks Completely Overlooked by the 10-Year Bull Market

The current bull market is now officially 10 years old. That anniversary took place on Saturday, March 9. The Great Recession was the worst modern-era recession, and it was followed ...
Read Full Story »

Top Analyst Upgrades and Downgrades: CSX, Intelsat, Kohl’s, NIO, Rio Tinto, TripAdvisor, VMware and More

Stocks were indicated to open marginally lower on Wednesday after Tuesday's sell-off. After the Dow Jones industrials had initially risen well over 3,000 points from its lows in January, investors ...
Read Full Story »

Major Pharma Sees Tremendous Rise in Short Interest

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »